088340 — Uracle Co Balance Sheet
0.000.00%
- KR₩34bn
- KR₩33bn
- KR₩44bn
Annual balance sheet for Uracle Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,815 | 9,497 | 10,228 | 20,676 | 11,204 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,496 | 9,913 | 8,738 | 11,145 | 11,736 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16,741 | 21,825 | 21,180 | 34,057 | 23,999 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,024 | 1,413 | 1,489 | 1,435 | 6,725 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 23,085 | 25,888 | 26,058 | 40,941 | 36,710 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9,392 | 10,125 | 5,794 | 7,504 | 8,432 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 14,094 | 13,673 | 9,720 | 12,587 | 17,364 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 8,991 | 12,214 | 16,339 | 28,353 | 19,347 |
| Total Liabilities & Shareholders' Equity | 23,085 | 25,888 | 26,058 | 40,941 | 36,710 |
| Total Common Shares Outstanding |